These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22923367)

  • 21. Modulating the Amyloidogenesis of α-Synuclein.
    Sivanesam K; Andersen NH
    Curr Neuropharmacol; 2016; 14(3):226-37. PubMed ID: 26517049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease.
    Cristóvão AC; Guhathakurta S; Bok E; Je G; Yoo SD; Choi DH; Kim YS
    J Neurosci; 2012 Oct; 32(42):14465-77. PubMed ID: 23077033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
    Münch G; Lüth HJ; Wong A; Arendt T; Hirsch E; Ravid R; Riederer P
    J Chem Neuroanat; 2000 Dec; 20(3-4):253-7. PubMed ID: 11207423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of phosphorylation in synucleinopathies: focus on Parkinson's disease.
    Cavallarin N; Vicario M; Negro A
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):471-81. PubMed ID: 20522010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
    Werner T; Horvath I; Wittung-Stafshede P
    J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.
    Kumari R; Kumar R; Kumar S; Singh AK; Hanpude P; Jangir D; Maiti TK
    J Biol Chem; 2020 Mar; 295(11):3466-3484. PubMed ID: 32005664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Rocha EM; De Miranda B; Sanders LH
    Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between Copper Chaperone Atox1 and Parkinson's Disease Protein α-Synuclein Includes Metal-Binding Sites and Occurs in Living Cells.
    Horvath I; Blockhuys S; Šulskis D; Holgersson S; Kumar R; Burmann BM; Wittung-Stafshede P
    ACS Chem Neurosci; 2019 Nov; 10(11):4659-4668. PubMed ID: 31600047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.
    Chen L; Wei Y; Wang X; He R
    PLoS One; 2010 Feb; 5(2):e9052. PubMed ID: 20140223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sticky situation: Aberrant protein-protein interactions in Parkinson's disease.
    Brown J; Horrocks MH
    Semin Cell Dev Biol; 2020 Mar; 99():65-77. PubMed ID: 29738882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease.
    Chu Y; Mickiewicz AL; Kordower JH
    Neurobiol Dis; 2011 Jan; 41(1):71-82. PubMed ID: 20816781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lewy body in Parkinson's disease and related neurodegenerative disorders.
    Wakabayashi K; Tanji K; Odagiri S; Miki Y; Mori F; Takahashi H
    Mol Neurobiol; 2013 Apr; 47(2):495-508. PubMed ID: 22622968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
    Luna E; Luk KC
    FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.